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Abstract
Objective: Whilst regular exercise is advocated for people with type 1 diabetes, the benefits of this therapy are poorly
delineated. Our objective was to review the evidence for a glycaemic benefit of exercise in type 1 diabetes.
Research Design and Methods: Electronic database searches were carried out in MEDLINE, Embase, Cochrane’s Controlled
Trials Register and SPORTDiscus. In addition, we searched for as yet unpublished but completed trials. Glycaemic benefit
was defined as an improvement in glycosylated haemoglobin (HbA1c). Both randomised and non-randomised controlled
trials were included.
Results: Thirteen studies were identified in the systematic review. Meta-analysis of twelve of these (including 452 patients)
demonstrated an HbA1c reduction but this was not statistically significant (standardised mean difference (SMD) 20.25; 95%
CI, 20.59 to 0.09).
Conclusions: This meta-analysis does not reveal evidence for a glycaemic benefit of exercise as measured by HbA1c.
Reasons for this finding could include increased calorie intake, insulin dose reductions around the time of exercise or lack of
power. We also suggest that HbA1c may not be a sensitive indicator of glycaemic control, and that improvement in
glycaemic variability may not be reflected in this measure. Exercise does however have other proven benefits in type 1
diabetes, and remains an important part of its management.
Citation: Kennedy A, Nirantharakumar K, Chimen M, Pang TT, Hemming K, et al. (2013) Does Exercise Improve Glycaemic Control in Type 1 Diabetes? A
Systematic Review and Meta-Analysis. PLoS ONE 8(3): e58861. doi:10.1371/journal.pone.0058861
Editor: Andrea Vergani, Children’s Hospital Boston, United States of America
Received October 18, 2012; Accepted February 7, 2013; Published March 15, 2013
Copyright:  2013 Kennedy et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors have no support or funding to report.
Competing Interests: The authors have read the journal’s policy and have the following conflicts: AK has received sponsorship to attend a scientific meeting
from NovoNordisk, RA has been on the advisory board for GSK, received honorariums and/or sponsorship to attend a scientific meeting from NovoNordisk, GSK,
Sanofi Aventis and Lilly, KH has been an expert witness in several legal cases, and PN has received advisory board invitations and speaker honorariums from
NovoNordisk. This declaration of interest does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
* E-mail: p.narendran@bham.ac.uk
Introduction
The current UK guidelines for exercise and physical activity are
that all individuals undertake at least 150 minutes of moderate-
intensity, or 75 minutes of high-intensity, aerobic physical activity
per week. [1] The American Diabetes Association (ADA) has
similar recommendations for all people with diabetes. [2] The
evidence base for these recommendations for patients with
diabetes is drawn largely from studies of the general population
and those with type 2 diabetes. [3] Studies on the benefits of
exercise in type 1 diabetes are less robust.
The currently recognised health benefits of exercise in type 1
diabetes have been reviewed previously. [3] To date, there is
evidence that exercise improves physical fitness, insulin resistance,
lipids and macrovascular risk in people with type 1 diabetes. [3]
However, the results of studies on exercise and glycaemic control
are conflicting. It is important to clarify this issue because
glycaemic control is considered by both patients and health care
professionals to be the mainstay of type 1 diabetes management.
Furthermore, and in contrast to studies in type 1 diabetes, a variety
of different forms (aerobic/resistance) of exercise have a demon-
strable benefit on glycaemic control in type 2 diabetes [4,5].
Here, we perform a systematic review and meta-analysis of
randomised controlled and non-randomised parallel group trials of
exercise training and glycaemic benefit in type 1 diabetes. We use
glycosylated haemoglobin (HbA1c) as the measure of glycaemic
control.
Methods
Data Sources and Searches
The electronic databases searched were MEDLINE (Ovid),
Embase (Ovid), Cochrane library (Wiley) and SPORTDiscus
(EBSCO) up until August 2011. An updated search of Medline was
performed up until May 2012. A variety of search terms were used
for individuals with type 1 diabetes (population) and physical
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activity (intervention). We did not restrict our search to the
outcome or study design to maximise the sensitivity of our search.
Nor did we place any date or language restrictions. Our secondary
search strategy included scanning bibliographies of the retrieved
articles and searching for unpublished studies using key trial
registries (clinicaltrials.gov, Current Controlled Trials Registry,
WHO hosted International Clinical Trials Registry Platform -
ICTRP). The primary search strategy is outlined in the Appendix
S1. The systematic review and meta-analysis is reported according
to the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines [6].
Study Selection
Inclusion criteria were defined based on population, interven-
tion, comparator, outcome and study design. Population were
adults and children with type 1 diabetes. Where the studies
reported data for both type 1 and 2 diabetes, authors were
contacted to obtain data for type 1 diabetes alone. Interventions
that aimed to increase the exercise through either supervised or
unsupervised training were included. We did not exclude studies
based on the intensity or type of exercise. Only trials that involved
a non-intervention group of participants with type 1 diabetes were
included. Studies where any other intervention was given to the
participants (e.g. dietary intervention) were only included if they
were given to both intervention and control arms. We included
both randomised and non randomised parallel controlled trials.
The primary outcome measure was change in HbA1c, with
HbA1c data extracted before and after the intervention. In those
studies where complete HbA1c data was not reported, we
contacted the authors for clarification. Our secondary outcome
measure was adverse events (hypoglycaemia).
Data Extraction and Study Quality
Initial selection was based on title and abstract. The original
article was obtained where it was unclear whether the study met
our inclusion criteria. Two reviewers (AK and MC) selected the
studies independently. Where there was disagreement between the
two reviewers, resolution was through a meeting with PN and KN.
Reasons for exclusion were documented and are available from
the authors on request. Where necessary, foreign language papers
were translated.
A data extraction and quality assessment form was developed
based on the template suggested by Centre for Review and
Dissemination (CRD) for systematic reviews in their guidelines
[7] Data extraction was performed by AK and checked by KN
for accuracy and for any missing information. Extracted data
included details of the study population, intervention character-
istics, outcome measures, and areas of potential bias. Biases
evaluated in randomised controlled trials (RCT) included
adequate sequence generation, satisfactory allocation conceal-
ment, follow-up and exclusion biases, blinding of outcome
assessors and intention to treat analysis. In non RCTs we
evaluated any baseline differences in participants, biases in
allocation, follow-up and exclusion and if analytical method was
specified in the study protocol.
Data Synthesis and Analysis
Each of the trials measured the outcome (HbA1c) both before
and after the intervention period, and for both control and
intervention arms. Trials did not report paired difference summary
statistics and so we could not obtain paired difference measures.
Rather, it was necessary to extract information on mean, standard
deviations, and number of participants both before and after the
intervention period and for both intervention and control arms for
each trial. For trials which reported the standard error of the mean
(SEM), we converted this to a standard deviation (SD) by
multiplying by the square root of the number of participants in
that arm. Any studies that only reported median values without
any measure of variation (such as inter-quartile range) could not be
included in the analysis.
For any trials which were multiple intervention arm trials we
extracted and summarised the trial information for each arm. We
then combined the intervention arms into a single combined arm
by estimating the weighted mean values (both before and after)
and estimating the weighted SD using the usual pooled standard
SD [9]. A similar approach was taken where there were two
control arms.
From the estimated mean and SD values for HbA1c both before
and after the intervention period, we then estimated the mean
difference (after-before) and SD in both the control and
intervention arms. It was necessary to estimate the SD for these
change effects as no estimates of correlation (or SDs of changes)
were reported in the original trial reports. We used a conservative
estimate for the correlation (0.5) as advocated [8].
All trials reported on the outcome HbA1c. However, because
HbA1c-DCCT standardisation only occurred in 1997, we
summarised treatment effects using the standardised mean
difference (SMD) of Hedges adjusted g [9].
Clinical, methodological and statistical heterogeneity were
explored. Clinical heterogeneity was explored by considering the
clinical diversity of the study participants in terms of their age and
study duration. Methodological heterogeneity was explored by
exploring variations in randomised and non randomised studies.
Statistical heterogeneity was tested using Cochran’s Q, a statistic
based on the chi-square test and quantified by the I-square test.
Results were then pooled across studies using a random effects
meta-analysis (since the degree of heterogeneity was too large to
warrant a fixed effects analysis) using the generic inverse variance
method. We pooled over all studies within the subgroups of child
and adult studies. We further investigated the effect of age and
duration of intervention by including the pooled (over control and
intervention arms) weighted mean age and duration as covariates
in a meta-regression model. Residual levels of heterogeneity were
investigated by comparing I-squared values before and after
adjustment for covariates (age and duration).
Risk of small study bias (or publication bias) was explored using
the contour enhanced funnel plot, stratifying by age of study
population (adult or child) and was further evaluated by the Egger
test.
Results
The database searches identified a total of 3,740 potentially
relevant papers (figure 1). One further paper was identified
through follow-up of a conference abstract (identified in the
original searches). After removing duplicates and screening by
considering titles and abstracts, 94 full-text articles were assessed.
Of these, 14 studies met the pre-determined inclusion criteria. One
study [10] did not report separate results for subjects with type 1
diabetes and these were not available after contacting the authors.
Hence, thirteen studies were considered suitable for inclusion in
the systematic review. The trials included both adults and children
(Table 1), with nine of the 13 trials recruiting children and young
adults (under 18 years of age). Many studies involved only aerobic
exercise (9/13), three studies involved both aerobic and resistance
activities, and one did not specify the exercise type.
Of the thirteen included studies, eight were randomised
controlled trials. Randomisation procedures were not reported in
Glycaemic Benefit of Exercise in Type 1 Diabetes
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any of these studies. In one study the reported randomisation
method (alternate subjects assigned to each group) resulted in it
being classified as non-randomised parallel group trial for the
purposes of this review. [11] In one study [12], the randomisation
process was carried out prior to consent being sought. Allocation
concealment and blinding were only reported in one study. [13]
Losses to follow-up and exclusions were documented in all studies.
Of the eight RCTs included in this study, five were analysed
according to the intention to treat principle. Four out of the five
non-randomised parallel group trials used a protocol based
analysis. Adherence to the training programme was not reported
in five studies. Where it was reported, adherence ranged between
62 and 100%. ‘Quality’ measures of the included studies are listed
in Table 2.
Exercise and HbA1c
The study by D’Hooge et al [13] could not be included in the
meta-analysis because median HbA1c without interquartile range
was reported. This study reported a 0.1% fall in median HbA1c in
the intervention group and a 0.2% fall in control group with
exercise.
The remaining 12 studies (452 patients) were included in the
meta-analysis. The overall, pooled data showed a non-significant
SMD reduction in HbA1c of 20.25% with exercise training (95%
CI, 20.59 to 0.09; p = 0.144; I-squared= 57.0%, Figure 2). A
greater SMD reduction in HbA1c was seen in the eight studies of
children and young adults, but here also this was not significant
(SMD, 20.37; 95% CI, 20.77 to 0.02; p = 0.066; I-
squared= 57.2%). No effect was seen in adult studies, of which
there were four, (SMD, 0; 95% CI, 20.5 to 0.5; p= 0.998; I-
squared= 23.5%).
In sensitivity analysis, there was no association between study
design and HbA1c reduction: SMD for randomised studies was
20.24 (95% CI 20.71 to 0.23) and for non-randomised studies
20.25 (95% CI 20.59 to 0.09). The degree of heterogeneity
observed in the randomised studies was I-squared = 66.4%
whereas this was lower in the non-randomised studies (I-
squared= 33.4%).
Meta regression of HbA1c against length of study duration
suggested a non-significant association between HbA1c reduction
and longer intervention (regression co-efficient, 20.034; 95% CI,
20.084 to 0.016; p = 0.163, figure 3A). Similarly, there was a non-
significant association of HbA1c and increasing age (regression co-
Figure 1. Flow diagram of articles identified.
doi:10.1371/journal.pone.0058861.g001
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efficient, 0.024; 95% CI, 20.013 to 0.060; p= 0.179, figure 3B).
The I-squared value before adjustment for co-variates was 57%,
and reduced to 50.4% after adjustment for age; and to 34.2% after
adjustment for duration.
The funnel plot (figure S1) suggests evidence of small study or
publication bias with under representation of studies reporting
negative effects (Eggers test p value = 0.003).
Exercise and Adverse Events
Hypoglycaemia frequency was mentioned in only five studies.
[11,13–16] One study [14] reported a similar frequency of
hypoglycaemia in both the intervention and control group.
Campaigne et al [16] reported only one episode of hypoglycae-
mia, which occurred during a training session. Salem et al [15]
found no difference in hypoglycaemia rates between the groups
exercising once or three times per week, but did not comment on
the hypoglycaemia frequency in the control group. Conversely,
Yki-Jarvinen et al [11] found that hypoglycaemia rates were
increased in the first two weeks of the training program but
diminished thereafter, and D’Hooge et al [13] reported frequent
hypoglycaemia episodes both during and after exercise in the
intervention group.
Discussion
This meta-analysis does not reveal a glycaemic benefit of
exercise in people with type 1 diabetes. However, sub-analyses
suggests that exercise may confer a glycaemic benefit in the young,
and when undertaken for longer periods. Whilst adverse event
reporting was poor, these studies demonstrate that exercise can be
undertaken by people with type 1 diabetes without significant
hypoglycaemia. This is important because qualitative studies have
previously reported hypoglycaemia to be a barrier to exercise in
type 1 diabetes [17,18].
We used predetermined inclusion criteria designed to identify as
many relevant studies as possible, and conducted this analysis in
accordance with PRISMA guidelines. [6] However, this study is
limited by the availability and quality of the obtained data. We
were unable to obtain the necessary data from all identified trials,
either because the data was not presented in a way that enabled
extraction for analysis or because we were unable to contact the
authors of the study. There is evidence from our analysis that
studies showing a negative effect of exercise on glycaemia may not
have been published (or identified during our search of unpub-
lished trials), and so that the effect size shown in this meta-analysis
is possibly overestimated.
There was considerable variation in the intervention (form and
intensity of exercise, duration of intervention), which may have
contributed to the heterogeneity of study results. However, ADA
guidance on exercise for people with type 1 diabetes is limited only
to duration and intensity [2], therefore, inclusion and comparison
of studies with different exercise interventions is, in our opinion
valid.
There are a number of potential explanations for the findings of
this meta-analysis. Firstly, the programmes of exercise may not
have been of sufficient duration. This is supported by our sub-
analysis which shows a trend for HbA1c reduction with longer
duration of intervention. Based on pooled data from these studies,
and assuming that the rate of glycaemic benefit persists in a linear
fashion, we estimate that studies of greater than 25 weeks duration
would be needed to obtain an HbA1c reduction in the region of
0.5%. This has implications for the design of future trials.
Secondly, as has been demonstrated in some studies of type 2
diabetes, [19] the intensity of the exercise program may be
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important. Inadequate reporting of exercise intensity in the
current type 1 diabetes studies makes this difficult to analyse.
Increased calorie intake, either as a source of fuel to manage
hypoglycaemia or as a reward, is another possible reason why our
analysis failed to detect a glycaemic benefit of exercise. The
interventions in the current studies were associated with additional
carbohydrate intake, and this is in line with ADA guidance as a
means of avoiding hypoglycaemia. However diet in general was
poorly recorded in these studies. Laaksonen et al [20] did attempt
to record dietary intake. In those participants where this was
achieved, dietary intake appeared similar between training and
control groups. There is therefore a need for studies in which
dietary intake is controlled for, or calorie intake clearly recorded.
There have been studies of combined diet and exercise interven-
tions [21] which were excluded from our analysis as the dietary
advice was given to the training arm alone. This study did show an
HbA1c reduction with combined dietary and physical activity
(8.962.6 to 8.662.1% vs 8.762.0 to 8.862.3% in the control
arm), although it did not reach significance. Insulin dose
adjustment is another approach to avoiding hypoglycaemia
around exercise, and a reduction in insulin dosage may account
for the absence of a reduction in HbA1c. Of the 11 studies that
reported insulin dosage pre- and post-training, five reported a
decrease in insulin requirement. [11,13,15,22,23] Those studies
with two intervention arms [15,22] both reported greater insulin
dose reductions in the higher intensity arms. However, six studies
reported no significant change in insulin dose with their training
intervention and only two of these reported a reduction in HbA1c.
[16,24] These studies therefore fail to clarify whether the lack of
glycaemic benefit of exercise can be attributed to changes in diet
or insulin dose.
HbA1c has been used as a measure of glycaemic control in our
analysis but this may not be the most appropriate measure of
glycaemic control. To illustrate, glycaemic variability has been
suggested to contribute to the development of microvascular
complications in type 2 diabetes. [25] Unfortunately, none of the
exercise studies in our analysis have examined glycaemic
variability. There is recent evidence from patients with insulin
treated type 2 diabetes that the time spent in hyperglycaemia is
reduced in the 24 hrs following exercise (without an increase in
hypoglycaemia), [26]. Conversely in type 1 diabetes, wide blood
glucose variability has been reported around exercise in the few
studies that have been conducted [27].
Figure 2. Results of studies of physical activity and glycaemic control (HbA1c) in type 1 diabetes patients according to age groups
of participants.
doi:10.1371/journal.pone.0058861.g002
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Figure 3. Metaregression by duration of study (A) and age of participants (B).
doi:10.1371/journal.pone.0058861.g003
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In contrast to our results, a recent meta-analysis by Tonoli et al
[28] reported a significant but small HbA1c lowering effect of
exercise in type 1 diabetes (Cohen’s d 20.27;95% CI 20.06 to
20.47). This paper however used different criteria for study
selection. It included studies with no control group, or control
subjects without diabetes. We purposefully excluded these trials to
control for the effect of participation in a clinical trial. Our meta-
analysis also included studies that were excluded in the Tonoli
analysis [11,14,15,16,22,23,24]. We believe these differences
accounts for the differing conclusions of the two meta-analyses.
Tonoli et al [28] did however agree that studies of strength
training exercises showed no overall improvement in glycaemic
control.
Overall there is a lack of large well-conducted studies on
glycaemic benefits of exercise in type 1 diabetes. Our systematic
review identified thirteen studies, from which data on 452 patients
has been used for analysis. In contrast, a recent meta-analysis of
exercise intervention in type 2 diabetes (which did detect an
HbA1c lowering effect) analysed 47 RCTs including more than
8500 patients. [4] Further research is therefore required to
demonstrate a glycaemic benefit of exercise in type 1 diabetes. We
would suggest the following areas are worth considering when
designing this research.
1) designing larger trials lasting at least six months
2) trial design that is randomised and well controlled (with
matched type 1 diabetic subjects and recording of dietary
intake)
3) examining the effect of exercise on glycaemic variability
4) examining the effect of exercise intensity, and the incorpo-
ration of a dietary programme on glycaemic benefit
5) examining the effect of age and duration of diabetes on
glycaemic benefit
Whilst this meta-analysis did not detect a glycaemic benefit to
exercise, there are other well defined benefits in type 1 diabetes.
These include reduction in macrovascular risk, mortality, and
improvement in wellbeing. [3] Therefore, we suggest exercise
should continue to play an important role in the management of
type 1 diabetes, whilst its glycaemic benefits are more thoroughly
investigated.
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